89 related articles for article (PubMed ID: 23697160)
41. A Compressive Review about Taxol
Gallego-Jara J; Lozano-Terol G; Sola-Martínez RA; Cánovas-Díaz M; de Diego Puente T
Molecules; 2020 Dec; 25(24):. PubMed ID: 33348838
[TBL] [Abstract][Full Text] [Related]
42. Modulation of alternative splicing induced by paclitaxel in human lung cancer.
Zhu Z; Chen D; Zhang W; Zhao J; Zhi L; Huang F; Ji H; Zhang J; Liu H; Zou L; Wang Y
Cell Death Dis; 2018 May; 9(5):491. PubMed ID: 29706628
[TBL] [Abstract][Full Text] [Related]
43. Baseline apoptosis of tumor cells as a response predictor to chemotherapy.
Provinciali M; Di Stefano G; Ciavattini A; Garzetti GG
J Natl Cancer Inst; 1997 Jun; 89(12):889-90. PubMed ID: 9196258
[No Abstract] [Full Text] [Related]
44. Molecular mechanisms and anti-cancer aspects of the medicinal phytochemicals rocaglamides (=flavaglines).
Li-Weber M
Int J Cancer; 2015 Oct; 137(8):1791-9. PubMed ID: 24895251
[TBL] [Abstract][Full Text] [Related]
45. Targeting apoptosis pathways in cancer and perspectives with natural compounds from mother nature.
Millimouno FM; Dong J; Yang L; Li J; Li X
Cancer Prev Res (Phila); 2014 Nov; 7(11):1081-107. PubMed ID: 25161295
[TBL] [Abstract][Full Text] [Related]
46. Apoptosis and taxol therapy.
McConley DJ; Davis DW
Cancer Biol Ther; 2002; 1(2):118-20. PubMed ID: 12212611
[No Abstract] [Full Text] [Related]
47. Molecular mechanisms of anticancer activities of polyphyllin VII.
Ahmad B; Rehman SU; Azizullah A; Khan MF; Din SRU; Ahmad M; Ali A; Tahir N; Azam N; Gamallat Y; Rahman KU; Ali M; Safi M; Khan I; Qamer S; Oh DH
Chem Biol Drug Des; 2021 Apr; 97(4):914-929. PubMed ID: 33342040
[TBL] [Abstract][Full Text] [Related]
48. [Glucuronyl paclitaxel (Taxol) derivatives as tumor activated prodrugs].
Bouvier E; Schmidt F; Monneret C
Ann Pharm Fr; 2005 Jan; 63(1):53-62. PubMed ID: 15803101
[TBL] [Abstract][Full Text] [Related]
49. Research progress on the source, production, and anti-cancer mechanisms of paclitaxel.
Yang YH; Mao JW; Tan XL
Chin J Nat Med; 2020 Dec; 18(12):890-897. PubMed ID: 33357719
[TBL] [Abstract][Full Text] [Related]
50. Medicinal properties of alpha-santalol, a naturally occurring constituent of sandalwood oil: review.
Bommareddy A; Brozena S; Steigerwalt J; Landis T; Hughes S; Mabry E; Knopp A; VanWert AL; Dwivedi C
Nat Prod Res; 2019 Feb; 33(4):527-543. PubMed ID: 29130352
[TBL] [Abstract][Full Text] [Related]
51. Seaweeds-derived compounds modulating effects on signal transduction pathways: A systematic review.
Juárez-Portilla C; Olivares-Bañuelos T; Molina-Jiménez T; Sánchez-Salcedo JA; Moral DID; Meza-Menchaca T; Flores-Muñoz M; López-Franco Ó; Roldán-Roldán G; Ortega A; Zepeda RC
Phytomedicine; 2019 Oct; 63():153016. PubMed ID: 31325683
[TBL] [Abstract][Full Text] [Related]
52. Progress in research on paclitaxel and tumor immunotherapy.
Zhu L; Chen L
Cell Mol Biol Lett; 2019; 24():40. PubMed ID: 31223315
[TBL] [Abstract][Full Text] [Related]
53. Human mesenchymal stromal cells primed with paclitaxel, apart from displaying anti-tumor activity, maintain their immune regulatory functions in vitro.
Conforti A; Biagini S; Starc N; Proia A; Pessina A; Alessandri G; Locatelli F; Bernardo ME
Cytotherapy; 2014 Jun; 16(6):868-70. PubMed ID: 24631286
[No Abstract] [Full Text] [Related]
54. Targeting apoptosis pathways in cancer--letter.
Safe S
Cancer Prev Res (Phila); 2015 Apr; 8(4):338. PubMed ID: 25627800
[No Abstract] [Full Text] [Related]
55. What is apoptosis, and why is it important?
Renehan AG; Booth C; Potten CS
BMJ; 2001 Jun; 322(7301):1536-8. PubMed ID: 11420279
[No Abstract] [Full Text] [Related]
56. Paclitaxel: biosynthesis, production and future prospects.
Howat S; Park B; Oh IS; Jin YW; Lee EK; Loake GJ
N Biotechnol; 2014 May; 31(3):242-5. PubMed ID: 24614567
[TBL] [Abstract][Full Text] [Related]
57. The paradox of paclitaxel neurotoxicity: Mechanisms and unanswered questions.
Gornstein E; Schwarz TL
Neuropharmacology; 2014 Jan; 76 Pt A():175-83. PubMed ID: 23978385
[TBL] [Abstract][Full Text] [Related]
58. nab-Paclitaxel mechanisms of action and delivery.
Yardley DA
J Control Release; 2013 Sep; 170(3):365-72. PubMed ID: 23770008
[TBL] [Abstract][Full Text] [Related]
59. Hexachlorobenzene as a differential modulator of the conventional and metronomic chemotherapy response in triple negative breast cancer cells.
Sanchez Y; Vasquez Callejas MA; Miret NV; Rolandelli G; Costas C; Randi AS; Español A
Explor Target Antitumor Ther; 2024; 5(2):278-295. PubMed ID: 38745771
[TBL] [Abstract][Full Text] [Related]
60. Resveratrol raises
Kong F; Zhang R; Zhao X; Zheng G; Wang Z; Wang P
Korean J Physiol Pharmacol; 2017 Sep; 21(5):465-474. PubMed ID: 28883751
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
